Shandong Boan Biotechnology Company., Limited. Class H (6955) Stock Statistics & Valuation Metrics

Shandong Boan Biotechnology Company., Limited. Class H has a market cap or net worth of HK$4.59B. The enterprise value is HK$6.81B.

Shandong Boan Biotechnology Company., Limited. Class H has 622,333,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shandong Boan Biotechnology Company., Limited. Class H’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Shandong Boan Biotechnology Company., Limited. Class H is 119.4. Shandong Boan Biotechnology Company., Limited. Class H’s PEG ratio is ―.

In the last 12 months, Shandong Boan Biotechnology Company., Limited. Class H had revenue of ― and earned ― in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Shandong Boan Biotechnology Company., Limited. Class H pays an annual dividend of ―, resulting in a dividend yield of ―

Shandong Boan Biotechnology Company., Limited. Class H upcoming earnings date is Mar 30, 2026, TBA (Confirmed).

Shandong Boan Biotechnology Company., Limited. Class H as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Shandong Boan Biotechnology Company., Limited. Class H has paid ― in taxes.

Shandong Boan Biotechnology Company., Limited. Class H EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Shandong Boan Biotechnology Company., Limited. Class H has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Shandong Boan Biotechnology Company., Limited. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―